Sensitivity to censored-at-random assumption in the analysis of time-to-event endpoints

Pharmaceutical Statistics

Volumn 15, Issue 3, 2016, Pages 216-229

  Lipkovich, Ilya ^a   Ratitch, Bohdana ^a   O'Kelly, Michael ^a  

^a IQVIA   (United States)

Author keywords

delta adjustment; multiple imputation; sensitivity analysis; time to event analysis; tipping point analysis

Indexed keywords

EXERCISE TEST; EXPERIMENTAL THERAPY; HUMAN; MODEL; STATISTICAL MODEL; BIOASSAY; CLINICAL TRIAL (TOPIC); COMPUTER SIMULATION; METHODOLOGY; PROCEDURES; STATISTICAL ANALYSIS; SURVIVAL ANALYSIS; TIME FACTOR;

CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; HUMANS; MODELS, STATISTICAL; RESEARCH DESIGN; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84978322299     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.1738     Document Type: Article

References (39)

1. Heitjan DF, Rubin DB,. Ignorability and coarse data. Annals of Statistics 1991; 19: 2244-2253.
2. National research council, Panel on handling missing data in clinical trials, Committee on national statistics division of behavioral and social sciences and education,. The Prevention and Treatment of Missing Data in Clinical Trials. The National Academies Press: Washington DC, 2010.
3. European medicines agency,. Guideline on Missing Data in Confirmatory Clinical Trials. EMA/CPMP/EWP/1776/99 Rev. 1. 2 July 2010.
4. Ratitch B, O'Kelly M, Tosiello R,. Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models. Pharmaceutical Statistics 2013; 12 (6): 337-347.
5. Rubin DB,. Inference and missing data. Biometrika 1976; 63: 581-592.
6. Rubin DB,. Multiple Imputation for Nonresponse in Surveys. John Wiley and Sons Inc.: New York, 1987.
7. Little RJA, Rubin DB,. Statistical Analysis with Missing Data (2nd edn). John Wiley and Sons, Inc.: New York, 2002.
8. Carpenter JR, Kenward MG,. Multiple Imputation and Its Application. John Wiley & Sons, Ltd.: West Sussex, UK, 2013.
9. Scharfstein D, Robins JM, Eddings W, Rotnitzky A,. Inference in randomized studies with informative censoring and discrete time-to-event endpoints. Biometrics 2001; 57 (2): 404-13.
10. Scharfstein D, Robins JM,. Estimation of the failure time distribution in the presence of informative censoring. Biometrika 2002; 89 (3): 617-634.
11. Zhang J, Heitjan DF,. Nonignorable censoring in randomized clinical trials. Clinical Trials 2005; 2: 488-496.
12. Rotnitzky A, Farall A, Bergesio A, Scharfstein D,. Analysis of failure time data under competing censoring mechanisms. JR Statist. Soc B 2007; 69 (3): 307-327.
13. Kaciroti NA, Raghunathan TE, Taylor JM, Julius S,. A Bayesian model for time-to-event data with informative censoring. Biostatistics 2012; 13 (2): 341-354.
14. Shardell M, Scharfstein DO, Bozzette SA,. 2007. Survival curve estimation for informatively coarsened discrete event-time data, Statistics in Medicine; 2184-202.
15. Daniels M, Hogan J,. Missing Data in Longitudinal Studies. Chapman & Hall: Boca Raton, FL, 2008.
16. Hill DH, Axinn WG, Thornton A,. Competing hazards with shared unmeasured risk factors. Sociological Methodology 1993; 23: 245-277.
17. Steele F, Diamond I, Wang D,. The determinants of the duration of contraceptive use in China: a multilevel multinomial discrete hazards modelling approach. Demography 1996; 33: 12-33.
18. Taylor M, Murray S, Hsu C-H,. Survival estimation and testing via multiple imputation. Statistics and probability letters 2002; 58: 221-232.
19. Zhao Y, Herring A, Zhou H, Ali M, Koch GG,. A multiple imputation method for sensitivity analyses for time-to-event data with possibly informative censoring. Journal of Biopharmaceutical Statistics 2014; 24 (2): 229-253.
20. Zhao Y, Preisser JS, Kock GG,. Sensitivity analysis for withdrawals in grouped time-to-event data. Statistics in Biopharmaceutical Research 2013; 6 (1): 41-54.
21. Molenberghs G, Kenward MG,. Missing Data in Clinical Studies. John Wiley and Sons, Ltd: Chichester, 2007.
22. Thijs H, Molenberghs G, Michiels B, Verbeke G, Curran D,. Strategies to fit pattern-mixture models. Biostatistics 2002; 3 (2): 245-265.
23. Rubin DB,. Multiple imputation after 18 + years. Journal of the American Statistical Association 1996; 91: 473-489.
24. Glynn RJ, Laird NM, Rubin DB,. Multiple imputation in mixture models for nonignorable nonresponse with follow-ups. Journal of the American Statistical Association 1993; 88 (423): 984-993.
25. Kaplan EL, Meier PL,. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53: 457-481.
26. Cox DR,. Regression models and life tables. Journal of the Royal Statistical Society, B 1972; 34: 187-220.
27. Friedman M,. Piecewise exponential models for survival data with covariates. The Annals of Statistics 1982; 10 (1): 101-113.
28. Meng X-L,. Multiple imputation inferences with uncongenial sources of input. Statistical Science 1994; 9 (4): 538-573.
29. Gilks WR, Best NG, Tan KKC,. Adaptive rejection metropolis sampling with Gibbs sampling. Applied Statistics 1995; 44: 455-472.
30. Yan X, Lee S, Li N,. Missing data handling methods in medical device clinical trials. Journal of Biopharmaceutical Statistics 2009; 19: 1085-1098.
31. Van Buuren S,. Flexible Imputation of Missing Data. Chapman & Hall/CRC Press: Boca Raton, FL, 2012.
32. Wilson EB, Hilferty MM,. The distribution of chi-squared. Proceedings of the National Academy of Sciences, vol. 17: Washington, 1931; 684-688.
33. Goria MN,. On the fourth root transformation of chi-square. Australian Journal of Statistics 1992; 34 (1): 55-64.
34. Berry G, Kitchin R, Mock P,. A comparison of two simple hazard ratio estimators based on the logrank test. Statistics in Medicine 1991; 10 (5): 749-755.
35. Steele F, Goldstein H,. A general multilevel multistate competing risks model for event history data, with an application to a study of contraceptive use dynamics. Journal of Statistical Modelling 2004; 4 (2): 145-159.
36. Hammer SM, Katzenstein DA, Hughes MD, Gundacker H, Schooley RT, Haubrich RH, Henry WK, Lederman MM, Phair JP, Niu M, Hirsch MS, Merigan TC, A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter,. The New England Journal of Medicine 1996; 335: 1081-1090.
37. Therneau TM, Grambsch PM,. Modeling Survival Data: Extending the Cox Model. Springer: New York, 2000.
38. Little R, Yau L,. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics 1996; 52: 1324-1333.
39. Carpenter JR, Roger JH, Kenward MG,. Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions and inference via multiple imputation. Journal of Biopharmaceutical Statistics 2013; 23 (6): 1352-1371.